Page last updated: 2024-10-23

bisbenzimidazole and Burkitt Lymphoma

bisbenzimidazole has been researched along with Burkitt Lymphoma in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frey, T1
Houck, DW1
Shenker, BJ1
Hoffman, RA1

Other Studies

1 other study available for bisbenzimidazole and Burkitt Lymphoma

ArticleYear
Bivariate flow karyotyping with air-cooled lasers.
    Cytometry, 1994, Jun-01, Volume: 16, Issue:2

    Topics: Air; Bisbenzimidazole; Burkitt Lymphoma; Cadmium; Chromomycin A3; Chromosomes, Human; DNA; DNA, Neop

1994